Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

The Interplay Between Coronavirus and Type I IFN Response

Evasion Mechanisms of the Type I Interferons Responses by Influenza A Virus

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options

A Commentary of “type I Interferon Deficiency Can Lead to Severe COVID-19” in 10 Remarkable Discoveries from 2020 in Nature

Protective versus Pathogenic Type I Interferon Responses during Virus Infections

Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond

The Dual Nature of Type I and Type II Interferons

Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils

Viral evasion of the interferon response at a glance

Insight into the Mechanisms of Coronaviruses Evading Host Innate Immunity.

The interaction between 2019-nCoV and interferon Ⅰ

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2

Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection

Innate immune sensing of coronavirus and viral evasion strategies

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism

Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.

The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies

The Roles of Type I Interferon in Co-infections with Parasites and Viruses, Bacteria, or Other Parasites.

Activation and evasion of type I interferon responses by SARS-CoV-2